Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Exploratory Ki-67 analyses.
2011 ◽
Vol 29
(15_suppl)
◽
pp. 500-500
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 76
(05)
◽
pp. 542-550
◽
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):
Keyword(s):